A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Aims To assess the efficacy and safety of the achievement of the NCEP goal of LDL-C ,1.8 mmol/L in elderly patients with ACS. Methods and results The relationship between LDL-C at 30 days after ACS and subsequent clinical outcomes were compared among elderly patients (aged !70 years) vs. younger counterparts in the PROVE IT-TIMI 22 trial, using the composite endpoint of death, myocardial infarction, or unstable angina. Among 634 elderly patients, the achievement of the NCEP goal was associateddoi:10.1093/eurheartj/ehl180 pmid:16887854 fatcat:qolchy5etzdoxboe3lyte7g7qa